| PERIOD ENDING | 29-Nov-09 | 30-Aug-09 | 31-May-09 | 1-Mar-09 | | Total Revenue | 46,088 | 42,518 | 36,697 | 35,497 | | Cost of Revenue | 32,327 | 31,570 | 27,489 | 27,385 | | | Gross Profit | 13,761 | 10,948 | 9,208 | 8,112 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,128 | 5,203 | 5,917 | 6,091 | | Non Recurring |
-
|
-
|
-
| 5,687 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,633 | 5,745 | 3,291 | (3,666) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 205 | 688 | 1,633 | | Earnings Before Interest And Taxes | 7,745 | 5,950 | 3,979 | (2,033) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 7,745 | 5,950 | 3,979 | (2,033) | | Income Tax Expense | 576 | 1,195 | 905 | (5,119) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,169 | 4,755 | 3,074 | 3,086 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 16,486 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,169 | 4,755 | 3,074 | 19,572 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,169 | $4,755 | $3,074 | $19,572 |
|
1.52% Nasdaq 0.00%
Income Statement
